T Liao, L Ding, P Wu, L Zhang, X Li, B Xu… - Drug Design …, 2020 - Taylor & Francis
Purpose Our recent reports have revealed that inhibiting NLRP3 activation reduces synovial
inflammation and fibrosis in knee osteoarthritis (KOA). Synovial inflammation is involved the …